News

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Improving diagnostics needs a culture change.

An analysis of participants in a trial measuring the efficacy of PrEP found that sex-driven dose timing—as opposed to daily dosing—was effective in preventing HIV, even in men who had sex less often.

Influenza vaccination offers protection against illness and death for heart disease patients. The possibility of treatment-resistant influenza. The earliest, strongest US flu season in 15 years. What’s new in flu news this week?

Ebola vaccines could be given as an emergency intervention to individuals exposed to the virus.

Observations about the body’s response to malaria infection can lead to new treatments for HIV and lupus, investigators believe.

Gathering policymakers and business leaders together to develop potential solutions lays groundwork for future real-world efforts.

The difference in outcomes was 4.7% with a 95% confidence interval on that difference of -10.3% to 1.0%. This fell short of non-inferiority which required that the lower limit of the difference in the outcome rates be >-10%.

New guidance issued by the CDC offers details on the dosing, efficacy and safety of tafenoquine for prevention and antirelapse therapy for malaria.

The FDA investigation of fruit mix linked to a recent outbreak has discovered 33 laboratory confirmed illnesses of Salmonella thus far.

Fifteen years after the launch of a program to help bring HIV treatment to low-income countries, an FDA analysis shows the program is working, but there is room for improvement.

In a phase 3 study comparing delafloxacin and moxifloxacin for community acquired bacterial pneumonia, delafloxacin was deemed well tolerated and effective by investigators.

A recent study reported the benefit of vaginal microbiome transplantation for the treatment of recurrent bacterial vaginosis.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of December 1, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The Typhoid Vaccine Acceleration Consortium reports that a single dose of a typhoid conjugate vaccine was effective in children aged 9 months to 16 years.

A new app is intended to crowdsource medical information regarding life-saving interventions with FDA-approved drugs as well as facilitate the development of novel drugs for neglected infectious diseases.

Low vaccination coverage contributed to a sharp rise in the number of circulating vaccine-derived poliovirus outbreaks worldwide from January 2018 to June 2019, according to the CDC.

A new study shows that patients with medical devices were more likely to have resistant infections.

Prior to this study’s publication, the literature about pediatric C diff infection was limited.

CDC investigators used HIV surveillance and pharmacy data to examine the status of HIV treatment and prevention in the United States.

The test is a new diagnostic tool that uses bacterial viability and a novel technology to detect bacterial colonization of Methicillin-resistant Staphylococcus aureus.

On December 3, 2019, the US Department of Health and Human Services announced the launch of program which will provide PrEP to people without prescription drug insurance coverage.

The PALM trial evaluated the safety and efficacy of several experimental treatments for Ebola in the Democratic Republic of Congo.

Jab could save 600,000 lives, and hundreds of millions in health care costs.

Authors of a new report published by CDC detail barriers to case-based surveillance in policy and technical infrastructure which need to be addressed in order to enhance national efforts surrounding the HIV epidemic.

Using genome sequencing could be a game-changer in tracing colonization related to health care-associated outbreaks.